Stock Quote AKN - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

What were the results of the latest earnings call for Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)?
What are the analysts ratings and price targets for Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)?
Compare Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN) to its industry peers.
What is Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN) core business model and revenue streams?
Who are the top holders of Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN) stock?

American Stock Exchange Lists Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global Index B

NEW YORK, Nov. 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Safety First Trust Series 2007-4...

Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product

Akorn, Inc. (AMEX: AKN) today announced that it has signed an Exclusive Supply Agreement with PrimaPharm, Inc., a privately-held...

Akorn, Inc. Announces Move to Nasdaq Global Market

Akorn, Inc. (AMEX:AKN) today announced that its common stock listing application for the Nasdaq Global Market (Nasdaq) has been...

Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)

Akorn, Inc. (AMEX: AKN) today announced the positive results of a Phase III pivotal trial for Akten?. The clinical trial was a...

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products

Akorn, Inc. (AMEX: AKN) today announced that it has signed a Definitive Agreement with Azad Pharma, a privately-held...

Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine AND

Akorn, Inc. (AMEX: AKN) and Strides Arcolab Limited (NSE: STAR, BSE: 532531) today announced that both Companies have agreed to...

Akorn, Inc. and Serum Institute of India, Ltd. Announce the Signing of a Definitive Development and Exclusive Distribution Agree

Akorn, Inc. (AMEX:AKN) and Serum Institute of India, Ltd. today announced that they have entered into a Definitive Development...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AKN - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is $ 0.00

What is the 1 year trading range for share price?

has traded in the range of $ 0.00 to $ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAPXT Rex 2X Long Apple Daily Target ETF	$ 28.49 (0.00%)	0
AAPWRoundhill AAPL WeeklyPay ETF	$ 0.00 (0.00%)	0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026	$ 26.3811 (0.00%)	0
AAAUGoldman Sachs Physical Gold ETF Shares	$ 28.76 (0.00%)	0
AAAAlternative Access First Priority CLO Bond ETF	$ 25.08 (0.00%)	0
AAPXT Rex 2X Long Apple Daily Target ETF	$ 28.49 (0.00%)	0
AAPWRoundhill AAPL WeeklyPay ETF	$ 0.00 (0.00%)	0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026	$ 26.3811 (0.00%)	0
AAAUGoldman Sachs Physical Gold ETF Shares	$ 28.76 (0.00%)	0
AAAAlternative Access First Priority CLO Bond ETF	$ 25.08 (0.00%)	0
AAPXT Rex 2X Long Apple Daily Target ETF	$ 28.49 (0.00%)	0
AAPWRoundhill AAPL WeeklyPay ETF	$ 0.00 (0.00%)	0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026	$ 26.3811 (0.00%)	0
AAAUGoldman Sachs Physical Gold ETF Shares	$ 28.76 (0.00%)	0
AAAAlternative Access First Priority CLO Bond ETF	$ 25.08 (0.00%)	0

SkeBallLarry 3 minutes ago

UpDate from DOGE >

Latest work
DOGE
Department of Government Efficiency
@DOGE
Striving for maximum government transparency.
DOGE
Department of Government Efficiency
@DOGE
All payments (and soon the justifications) will be posted

SkeBallLarry 4 minutes ago

benhor 4 minutes ago

$STSS Rising on Pre-Market

0.4099 +0.11 38.15%

STSS

SkeBallLarry 5 minutes ago

benhor 5 minutes ago

$STSS Rising on Pre-Market

0.4099 +0.11 38.15%

STSS

SkeBallLarry 6 minutes ago

benhor 6 minutes ago

$STSS Rising on Pre-Market

0.4099 +0.11 38.15%

STSS

HyperPirate75 9 minutes ago

https://www.perplexity.ai/page/stem-cell-therapy-reverses-dia-clGsnmywR4ugKm9tiVEiEQ Look at this guys, this is our time to shine !!!

PKTX

eagle8 9 minutes ago

Thank you ILT.
I still have a few friends who want to buy but all possibilities here in Holland have been exhausted.
Crazy, selling and not buying.
Even a blind person can see how it is manipulated here.
I also suspect that the MM's do this to try to prevent a huge short

NWBO

ducci1 9 minutes ago

Charts: SPX 60 min---14 Days in the Falling Channel ?? VIX--14 Days Bouncing off Da 15 min Red Line ! Not over till VIX can stay below Da 15 min Red Line ?? (233 EMA )

SPY

JohnnyHydrogen 10 minutes ago

Dang that sounds awesome. LFG!

FCEL

ducci1 14 minutes ago

Pivot Calcs: SPX Pivot 5740----R1--5813----R2--5856----S1--5696----S2--5612-----SPY Pivot 572----R1--580----S1--567----ES Pivot 5733----VIX Pivot 24.34 !!LOL!!

SPY

Guzzi62 19 minutes ago

LOL,

You forgot to add, in my opinion!!!

Opinions are like axxxxxx, everyone got one.

I think a big player is standing in the sidelines ready to go in right after approval, IMO.

NWBO

Investor082 29 minutes ago

Let’s take baby steps. First goal, hit annual revenue of $12M from April 2025 to April 2026. In the following year, secure modest reimbursement approval in UK by end of 2026, and hit annual revenue of $25-30M in 2027.

Hopefully, they can then quickly get to $100M in annual revenue by

NWBO

fuagf 37 minutes ago

Remember 2019, think more to come - Amid Trump Tariffs, Farm Bankruptcies And Suicides Rise

"Get In Losers, We’re Going Losing.
MAGA’s Gonna Be Too Poor Soon To Own the Libs "

By Chuck Jones, Senior Contributor.
I cover technology companies, worldwide econ

surfkast 41 minutes ago

The major dilution happened in just two years. 584,750,000 as of February 28, 2023
Outstanding Shares 3,537,750,000 03/07/2025
Digging deeper we find that there was still a balance of 5,771,160 convertible preferred shares on November .30, 2024. These can convert into over 144 billion

VTXB

edbi46 42 minutes ago

On REDDIT 3 months ago:
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an el

BMI LMT QUBT

JMCK6193 46 minutes ago

Gonna be a good'un this week gals and gents

$NXPL 💪

NXPL

okwife 49 minutes ago

WHY ISN'T BTC ON THIS LIST?https://x.com/GmvMinh/status/1898000353817510295

BTCUSD

Nemesis18 51 minutes ago

>> The share price will be at $50 or $100 regardless of the uplist

NWBO

fuagf 52 minutes ago

LOL Neat new border - analysis - To make America great, Donald Trump is undoing its greatness as global stock markets fall

By Alan Kohler
11 hours ago

["Shit, should have thought it through better."]

https://live-production.wcms.abc-cdn.net.au/48

getmenews 55 minutes ago

2.50, one more time, then

XRPUSD

Hoghead7 59 minutes ago

Hot off the presses
https://u29265312.ct.sendgrid.net/ls/click?upn=u001.AGVir0q-2FyZWbZ5ev3cZBUkEleMvRVzeSDmm68mD8cr13GDagsfw6w1sfhJ8dxDUGVZH0yIbpjC3dMDbQG5Y1IZXM5s4T1FLjIK-2BW9DP6z8a0No-2FX76IdPVdBNaUhJAnpwRVFq7tVWyudg4iNMnyAtHKjBld9IhPkU-2Fejm9Ap7L337i6NDGg-2F8wRcw40RAm7u8ATSHEDF6v45HyH8s-2

FCEL

getmenews 1 hour ago

What's the purpose of congressional hearings?
How many Countries have filed Bankruptcy, anyone?
Please stop spewing nonsense talk

If I had to guess, your disappointment with my 16k call on BTC

Good Luck catching the bottom

GMN

BTCUSD

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

AKN Latest News

American Stock Exchange Lists Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global Index B

Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product

Akorn, Inc. Announces Move to Nasdaq Global Market

Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products

Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine AND

Akorn, Inc. and Serum Institute of India, Ltd. Announce the Signing of a Definitive Development and Exclusive Distribution Agree

Akorn, Inc. and Natco Pharma Limited Add Two Injectable Drug Products To API Supply and Margin Sharing Agreement

Akorn, Inc. Reports Third Quarter 2006 Revenues of $14.5 million and 41% Gross Margin

Akorn, Inc. Announces Third Quarter 2006 Earnings Release and Conference Call Information

AKN - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN) Quote

Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

AKN Latest News

American Stock Exchange Lists Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global Index B

Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product

Akorn, Inc. Announces Move to Nasdaq Global Market

Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products

Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine AND

Akorn, Inc. and Serum Institute of India, Ltd. Announce the Signing of a Definitive Development and Exclusive Distribution Agree

Akorn, Inc. and Natco Pharma Limited Add Two Injectable Drug Products To API Supply and Margin Sharing Agreement

Akorn, Inc. Reports Third Quarter 2006 Revenues of $14.5 million and 41% Gross Margin

Akorn, Inc. Announces Third Quarter 2006 Earnings Release and Conference Call Information

AKN - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Go Ad-Free

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE